作者: Jatinder Kaur , Ajay Matta , Ipshita Kak , Gunjan Srivastava , Jasmeet Assi
DOI: 10.1002/IJC.28473
关键词: Survival analysis 、 Hazard ratio 、 Oncology 、 Dysplasia 、 Internal medicine 、 Predictive marker 、 Biomarker (medicine) 、 Oral Dysplasia 、 S100A7 、 Biology 、 Malignant transformation 、 Pathology
摘要: Early detection of oral lesions (OLs) at high risk cancer development is utmost importance for intervention. There an urgent unmet clinical need biomarkers that allow identification high-risk OLs. Recently, we identified and verified a panel five candidate protein namely S100A7, prothymosin alpha, 14-3-3ζ, 14-3-3σ heterogeneous nuclear ribonucleoprotein K using proteomics to distinguish OLs with dysplasia cancers from normal tissues. The objective our study was evaluate the potential these dysplastic development. Using immunohistochemistry, analyzed expressions in 110 patients biopsy-proven known outcome determined their correlations p16 expression HPV 16/18 status. Kaplan–Meier survival analysis showed reduced cancer-free (OCFS) 68.6 months (p = 0.007) showing cytoplasmic S100A7 overexpression when compared weak or no immunostaining cytoplasm (mean OCFS 122.8 months). Multivariate Cox regression revealed as most significant marker associated 0.041, hazard ratio 2.36). In conclusion, suggested identifying